These pathology‐relevant tools will now be useful to define how IRE1 signals toward XBP1s or RIDD are regulated at the level of IRE1 and how those two signaling arms quantitatively interact to drive specific tumor characteristics. The gene discussed is ERN1; the disease is neoplasm.